Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania
Health & Medicine
In multiple sclerosis, the immune system goes rogue, improperly attacking the body’s own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Michael A. Nutter
Penn Center for Innovation Launch Celebration
Nov. 17, 2014
The Penn Center for Innovation, a new initiative that will provide the infrastructure, leadership and resources needed to transfer promising Penn inventions, know-how and related assets into the marketplace for the public good, will be formally launched at an event on Monday, November 17.
Gutmann, Nutter, Bonnell and Swartley will discuss how PCI will accelerate the translation of Penn discoveries and ideas into commercial products, businesses, and services, as well as the role the University plays in the local, national and global entrepreneurial ecosystem.
Top Penn researchers and members of the business and venture capital community will have the opportunity to meet at a reception to follow.
Attendance is free and open to the public, but email registration is mandatory.
By Madeleine Stone @themadstone
A $10 million gift to the University of Pennsylvania to name the Paul F. Harron, Jr.
Penn Medicine's Basser Research Center for BRCA Announces $6.9 Million in New Grants to Further BRCA1 and BRCA2 Mutation Research
The University of Pennsylvania’s Basser Research Center for BRCA has announced $6.9 million to resea
A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a life-threatening condition also known as “bubble boy” disease, appears to be both effective and safe, according to an international clinical trial with sites in Boston, Cincinnati, Los Angeles, London, a
A first-of-its-kind set of questions included in the Internal Medicine In-Training Examination (IM-ITE) illustrates the need to better evaluate resident proficiency in high-value care (HVC), according to a new study published in Annals of